Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Calmels

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Blood|February 21, 2009
Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic originHugues de Lavallade, Patrick Ladaique, Claude Lemarié, et al.
Medecine Sciences : M/S|June 19, 2014
[Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products]Christian Chabannon, Florence Sabatier, Emmanuelle Rial-Sebbag, et al.
Journal of Translational Medicine|November 4, 2022
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cellsBechara Mfarrej, Olivier Vicari, Sarah Ouffai, et al.
Bulletin Du Cancer|October 11, 2020
[CD34+ cell selection methods, quality controls and expected results: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Boris Calmels, Éric Gautier, Alessandra Magnani, et al.
Blood|September 24, 2004
Low-dose total body irradiation causes clonal fluctuation of primate hematopoietic stem and progenitor cellsMikko O Laukkanen, Ken Kuramoto, Boris Calmels, et al.
Transfusion|April 26, 2005
Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMateClaude Lemarie, Boris Calmels, Carine Malenfant, et al.
Cytotherapy|October 18, 2017
Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell graftsBechara Mfarrej, Guillaume Bouchet, Jérôme Couquiaud, et al.
Cytotherapy|April 3, 2026
Equivalent CD34+ selection outcomes with CliniMACS prodigy and CliniMACS plus, enabling cryopreserved product processingAnne-Line Chateau, Clémence Demerle, Pierre Lignee, et al.
American Journal of Hematology|January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimenAude Collignon, Boris Calmels, Samia Harbi, et al.
Transfusion|August 16, 2013
Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan areaJeremy Magalon, Lise Marie Billard-Daufresne, Chantal Gilbertas, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Blood|February 21, 2009
Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic originHugues de Lavallade, Patrick Ladaique, Claude Lemarié, et al.
Medecine Sciences : M/S|June 19, 2014
[Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products]Christian Chabannon, Florence Sabatier, Emmanuelle Rial-Sebbag, et al.
Journal of Translational Medicine|November 4, 2022
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cellsBechara Mfarrej, Olivier Vicari, Sarah Ouffai, et al.
Bulletin Du Cancer|October 11, 2020
[CD34+ cell selection methods, quality controls and expected results: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Boris Calmels, Éric Gautier, Alessandra Magnani, et al.
Blood|September 24, 2004
Low-dose total body irradiation causes clonal fluctuation of primate hematopoietic stem and progenitor cellsMikko O Laukkanen, Ken Kuramoto, Boris Calmels, et al.
Transfusion|April 26, 2005
Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMateClaude Lemarie, Boris Calmels, Carine Malenfant, et al.
Cytotherapy|October 18, 2017
Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell graftsBechara Mfarrej, Guillaume Bouchet, Jérôme Couquiaud, et al.
Cytotherapy|April 3, 2026
Equivalent CD34+ selection outcomes with CliniMACS prodigy and CliniMACS plus, enabling cryopreserved product processingAnne-Line Chateau, Clémence Demerle, Pierre Lignee, et al.
American Journal of Hematology|January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimenAude Collignon, Boris Calmels, Samia Harbi, et al.
Transfusion|August 16, 2013
Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan areaJeremy Magalon, Lise Marie Billard-Daufresne, Chantal Gilbertas, et al.
Pageof 7